JP Morgan Chase’s Radius Health, Inc. RDUS Stock Holding History

JP Morgan Chase’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$773K	–	5983
2019 Q3	$773K	Sell	30,000 -35,000	-54%	-$858K	﹤0.01%	3981
2019 Q2	$1.54M	Sell	65,000 -33,000	-34%	-$721K	﹤0.01%	3554
2019 Q1	$1.95M	Buy	98,000 +39,000	+66%	+$711K	﹤0.01%	3348
2018 Q4	$973K	Buy	+59,000	New	+$993K	﹤0.01%	3761
2018 Q3	–	Sell	-36,000	Closed	-$1.06M	–	5906
2018 Q2	$1.06M	Sell	36,000 -94,000	-72%	-$2.97M	﹤0.01%	3804
2018 Q1	$4.67M	Buy	130,000 +55,000	+73%	+$1.99M	﹤0.01%	2638
2017 Q4	$2.38M	Buy	+75,000	New	+$2.35M	﹤0.01%	3211
2016 Q1	–	Sell	-35,000	Closed	-$2.15M	–	5034
2015 Q4	$2.15M	Buy	+35,000	New	+$2.21M	﹤0.01%	2719

Other funds holding RDUS

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

JP Morgan Chase's RDUS Position: Q3 2022 in Review

JP Morgan Chase sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 233,851 shares — an estimated $2.42M sold.

JP Morgan Chase first reported a position in RDUS in Q2 2014 and held it in 33 quarters. The position peaked at $14.2M in Q3 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

JP Morgan Chase reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
JP Morgan Chase sold 233,851 Radius Health, Inc. shares in Q3 2022, an estimated $2.42M.
JP Morgan Chase first reported a position in Radius Health, Inc. in Q2 2014 and held it in 33 quarters.
JP Morgan Chase's Radius Health, Inc. position peaked at $14.2M in Q3 2016.
1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.